spot_img
Friday, August 12, 2022
More
    HomeHealthUniqure’s Huntington’s gene therapy lowers key protein in small trial

    Uniqure’s Huntington’s gene therapy lowers key protein in small trial

    -



    A gene remedy for Huntington’s illness made by the Dutch biotech agency Uniqure confirmed early promise in a preliminary research of a handful of sufferers, the corporate stated Wednesday.

    Evaluable knowledge had been obtainable from solely 4 sufferers who had obtained the remedy, code-named AMT-130, and three in a management group who had undergone a sham remedy. All had been within the early phases of the deadly neurodegenerative illness.

    Unlock this text by subscribing to STAT+ and revel in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,433FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts